Condition: Sarcopenia · Sponsor: University of Saskatchewan
GLP-1 receptor agonists are effective for weight loss, but significant muscle mass is lost as a proportion of this weight loss. This study combines resistance-training and creatine supplementation to try to prevent this loss of muscle mass.
This description comes directly from the study's public registry record.
Philip D Chilibeck, PhD · 306-966-1072 · phil.chilibeck@usask.ca
Always discuss trial participation with your own doctor first.
| University of Saskatchewan | Saskatoon, SK - Saskatchewan, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07625202